These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 21305147)

  • 21. In vitro inhibition of human immunodeficiency virus type-1 (HIV-1) reverse transcriptase by gold(III) porphyrins.
    Sun RW; Yu WY; Sun H; Che CM
    Chembiochem; 2004 Sep; 5(9):1293-8. PubMed ID: 15368585
    [No Abstract]   [Full Text] [Related]  

  • 22. Rapid detection of drug resistant HIV -1 to reverse transcriptase and protease inhibitors in HIV-infected patients receiving highly active antiretroviral therapies.
    Yu M; Kabat W; Wang J
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Dec; 14(4):325-9. PubMed ID: 11471017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new strategy based on recombinant viruses as a tool for assessing drug susceptibility of human immunodeficiency virus type 1.
    Garcia-Perez J; Sanchez-Palomino S; Perez-Olmeda M; Fernandez B; Alcami J
    J Med Virol; 2007 Feb; 79(2):127-37. PubMed ID: 17177310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temporal characterization of drug resistance associated mutations in HIV-1 protease and reverse transcriptase in patients failing antiretroviral therapy.
    Santoro MM; Svicher V; Gori C; Zaccarelli M; Tozzi V; Forbici F; D'Arrigo R; Trotta MP; Bellocchi MC; Visco-Comandini U; Cenci A; Bertoli A; Narciso P; Antinori A; Perno CF; Ceccherini-Silberstein F
    New Microbiol; 2006 Apr; 29(2):89-100. PubMed ID: 16841549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of the ribonuclease H and DNA polymerase activities of HIV-1 reverse transcriptase by N-(4-tert-butylbenzoyl)-2-hydroxy-1-naphthaldehyde hydrazone.
    Borkow G; Fletcher RS; Barnard J; Arion D; Motakis D; Dmitrienko GI; Parniak MA
    Biochemistry; 1997 Mar; 36(11):3179-85. PubMed ID: 9115994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biological and biochemical anti-human immunodeficiency virus activity of UC 38, a new non-nucleoside reverse transcriptase inhibitor.
    McMahon JB; Buckheit RW; Gulakowski RJ; Currens MJ; Vistica DT; Shoemaker RH; Stinson SF; Russell JD; Bader JP; Narayanan VL; Schultz RJ; Brouwer WG; Felauer EE; Boyd MR
    J Pharmacol Exp Ther; 1996 Jan; 276(1):298-305. PubMed ID: 8558446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro selection of mutations in human immunodeficiency virus type 1 reverse transcriptase that confer resistance to capravirine, a novel nonnucleoside reverse transcriptase inhibitor.
    Sato A; Hammond J; Alexander TN; Graham JP; Binford S; Sugita K; Sugimoto H; Fujiwara T; Patick AK
    Antiviral Res; 2006 Jun; 70(2):66-74. PubMed ID: 16472877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of NNRTIs on HIV reverse transcriptase dimerization.
    Tachedjian G; Goff SP
    Curr Opin Investig Drugs; 2003 Aug; 4(8):966-73. PubMed ID: 14508881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples.
    Venturi G; Catucci M; Romano L; Corsi P; Leoncini F; Valensin PE; Zazzi M
    J Infect Dis; 2000 Feb; 181(2):740-5. PubMed ID: 10669367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-1 reverse transcriptase inhibitors.
    El Safadi Y; Vivet-Boudou V; Marquet R
    Appl Microbiol Biotechnol; 2007 Jun; 75(4):723-37. PubMed ID: 17370068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fullerene derivatives as dual inhibitors of HIV-1 reverse transcriptase and protease.
    Yasuno T; Ohe T; Kataoka H; Hashimoto K; Ishikawa Y; Furukawa K; Tateishi Y; Kobayashi T; Takahashi K; Nakamura S; Mashino T
    Bioorg Med Chem Lett; 2021 Jan; 31():127675. PubMed ID: 33161121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A search for anti-viral properties in Panamanian medicinal plants. The effects on HIV and its essential enzymes.
    Matsuse IT; Lim YA; Hattori M; Correa M; Gupta MP
    J Ethnopharmacol; 1999 Jan; 64(1):15-22. PubMed ID: 10075118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitors from natural products to HIV-1 reverse transcriptase, protease and integrase.
    Jiang Y; Ng TB; Wang CR; Zhang D; Cheng ZH; Liu ZK; Qiao WT; Geng YQ; Li N; Liu F
    Mini Rev Med Chem; 2010 Dec; 10(14):1331-44. PubMed ID: 21175425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation of adenosine, iso-sinensetin and dimethylguanosine with antioxidant and HIV-1 protease inhibiting activities from fruiting bodies of Cordyceps militaris.
    Jiang Y; Wong JH; Fu M; Ng TB; Liu ZK; Wang CR; Li N; Qiao WT; Wen TY; Liu F
    Phytomedicine; 2011 Jan; 18(2-3):189-93. PubMed ID: 20576416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ellagic acid & gallic acid from Lagerstroemia speciosa L. inhibit HIV-1 infection through inhibition of HIV-1 protease & reverse transcriptase activity.
    ; Modi M; Goel T; Das T; Malik S; Suri S; Rawat AK; Srivastava SK; Tuli R; Malhotra S; Gupta SK
    Indian J Med Res; 2013 Mar; 137(3):540-8. PubMed ID: 23640562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-HIV-1 activity, protease inhibition and safety profile of extracts prepared from Rhus parviflora.
    Modi M; Nutan ; Pancholi B; Kulshrestha S; Rawat AK; Malhotra S; Gupta S
    BMC Complement Altern Med; 2013 Jul; 13():158. PubMed ID: 24059266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytotoxic and HIV-1 enzyme inhibitory activities of Red Sea marine organisms.
    Ellithey MS; Lall N; Hussein AA; Meyer D
    BMC Complement Altern Med; 2014 Feb; 14():77. PubMed ID: 24568567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective and facile assay of human immunodeficiency virus protease activity by a novel fluorogenic reaction.
    Yu Z; Kabashima T; Tang C; Shibata T; Kitazato K; Kobayashi N; Lee MK; Kai M
    Anal Biochem; 2010 Feb; 397(2):197-201. PubMed ID: 19852926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gold compounds as therapeutic agents for human diseases.
    Berners-Price SJ; Filipovska A
    Metallomics; 2011 Sep; 3(9):863-73. PubMed ID: 21755088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An assay to monitor HIV-1 protease activity for the identification of novel inhibitors in T-cells.
    Hilton BJ; Wolkowicz R
    PLoS One; 2010 Jun; 5(6):e10940. PubMed ID: 20532177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.